Microbial transformation of 5-episinuleptolide

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 4, 2007, Pages 537-540

  Kamel, Haidy Nasr ^a   Fronczek, Frank Rolf ^b   Khalifa, Sherief Ibrahim ^c   Slattery, Marc ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Suez Canal University   (Egypt)

Author keywords

Cembranoid; Microbial transformation; Sinularia; Streptomyces lavendulea

Indexed keywords

5 EPISINULEPTOLIDE; 6 ALPHA HYDROXY 5 EPISINULEPTOLIDE; DITERPENE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCATALYST; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOCHEMISTRY; X RAY DIFFRACTION;

BIOTRANSFORMATION; DITERPENES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; REFERENCE STANDARDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; STREPTOMYCES;

EID: 34147164399     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.537     Document Type: Article

References (22)

1. Kamel H. N., Slattery M., Pharmaceutical Biol., 43, 1-17 (2005).
2. Kobayashi M., Nakagawa T., Mitsuhashi H., Chem. Pharm. Bull., 27, 2382-2387 (1979).
3. Fujiki H., Suganuma M., Suguri H., Yoshizawa S., Takagi K., Kobayashi M., J. Cancer Res. Clin. Oncology, 49, 25-28 (1989).
4. Katsuyama I., Fahmy H., Zajwony J. K., Khalifa S. I., Kilada R. W., Konoshima T., Takasaki M., Tokuda H., J. Nat. Prod., 65, 1809-1814 (2002).
5. El Sayed K. A., Hamann M. T., Waddling C. A., Jensen C., Lee S. K., Dunstan C. A., Pezzuto J. M., J. Org. Chem., 63, 7449-7455 (1998).
6. Sawant S. S., Sylvester P. W., Avery M. A., Desai P., Youssef D. T. A., El Sayed K. A., J. Nat. Prod., 67, 2017-2023 (2004).
7. Riva S., Curr. Opinion Chem. Biol., 5, 106-111 (2001).
8. Sawant S. S., Youssef D. T. A., Riland J,, Ferniz M., Marchetti D., El Sayed K. A., J. Nat. Prod., 69, 1010-1013 (2006).
9. Bowden B. F., Coll J. C., Mitchell S. J., Mulder J., Stokie G. J., Aust. J. Chem., 31, 2049-2056 (1978).
10. Turner K. E., Bowden B. F., Stokie G. J., Howard C. J., Acta Cryst., B35, 1283-1284 (1979).
11. Lakshmi V., Schmitz F. J., J. Nat. Prod., 49, 728-730 (1986).
12. Duh C., Hou R., Wang S., Chang T., Chin. Pharm. J., 45, 399-407 (1993).
13. Wahlberg I., Eklund A., Prog. Chem. Org. Natural Products, 59, 141-294 (1992).
14. Sato A., Fenical W., Qi-tai Z., Clardy J., Tetrahedron, 41, 4303-4308 (1985).
15. Shoji N., Umeyama A., Arihara S., J. Nat. Prod., 56, 1651-1653 (1993).
16. Tseng Y., Atallah A. F., Dai C., Chiang M. Y., Sheu J., Org. Lett., 7, 3813-3816 (2005).
17. Takaki H., Koganemaru R., Iwakawa Y., Higuchi R., Miyamato T., Biol. Pharm. Bull., 26, 380-382 (2003).
18. The sequence of these events is unkown.
19. Kieslich K., "Microbial Transformation of Non-steroid Cyclic Compounds," John Wiley & Sons, New York, 1976.
20. Sariaslani F. S., Trower M. K., Buchholz S. E., Dev. Ind. Microbiol., 30, 161-170 (1989).
21. Ishihara K., Yamaguchi H., Hamda H., Nakajima N., Nakamura K., J. Mol. Catalysis B: Enzymatic, 10, 429-434 (2000).
22. Muhammad I., Bedir E., Khan S., Tekwani B. L., Khan I. A., Takamatsu S., Pelletier J., Walker L. A., J. Nat. Prod., 67, 772-777 (2004).